475 studies found for:    butyrylcholinesterase
Show Display Options
Rank Status Study
1 Recruiting Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Cholinesterase Inhibitor;   Drug: Placebo
2 Completed Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects
Condition: Butyrylcholinesterase Deficiency
Intervention: Drug: AZD8848
3 Not yet recruiting Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine
4 Completed
Has Results
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: memantine
5 Completed A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly
Condition: Healthy
Interventions: Drug: Human butyrylcholinesterase (HuBChE) derived from human plasma;   Drug: Placebo: Normal saline
6 Completed Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered Intravenously
Conditions: Chemical Terrorism;   Chemical Warfare
Interventions: Drug: Human Butyrylcholinesterase (HuBChE) derived from human plasma;   Drug: Placebo: Normal saline
7 Completed Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults
Conditions: Mental Health;   Geriatrics
Interventions: Drug: donepezil;   Drug: Placebo (cornstarch)
8 Recruiting A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease
Condition: Lewy Body Disease
Intervention: Drug: Cholinesterase Inhibitors (Rivastigmine, Aricept, Galantamine)
9 Not yet recruiting Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Rivastigmine
10 Completed Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment
Condition: Late Onset Alzheimer
Intervention:
11 Completed Estimation of Functional Liver Reserve Using Cholinesterases
Conditions: Hepatocellular Carcinoma;   Cirrhosis;   Liver Neoplasm;   Liver Disease
Intervention:
12 Active, not recruiting Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects
Condition: Cocaine Addiction
Interventions: Drug: TV-1380 150 mg;   Drug: TV-1380 300 mg;   Drug: Placebo
13 Recruiting Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients
Condition: Postoperative Delirium
Intervention:
14 Completed Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: lecozotan SR (SRA-333)
15 Active, not recruiting Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
16 Recruiting Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
Conditions: Traumatic Brain Injury;   Cognitive Impairment
Intervention: Drug: Rivastigmine Transdermal Patch
17 Completed
Has Results
Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
Condition: Pediculosis
Intervention: Drug: MALG (malathion) Treatment
18 Completed Use of Donepezil for Treatment of Cocaine Dependence
Condition: Cocaine Abuse and Dependence
Intervention: Drug: Donepezil, 5 mg daily
19 Completed To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
Condition: Alzheimer's Disease
Intervention: Drug: Atorvastatin
20 Completed Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone
Condition: Elderly
Intervention: Drug: Donepezil

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years